Dr Emma Allott is a molecular cancer epidemiologist whose research integrates epidemiologic methods and design with molecular tumour profiling to identify mechanisms linking dietary and lifestyle factors with cancer risk and progression.

She directs -omics and immunohistochemistry analyses of archival tissue specimens to generate molecular epidemiology resources, and leads a research program focused on the role of statin use, high serum cholesterol and dysregulated tumour lipid metabolism in prostate cancer progression.